A two-stage laser surgery for fibroplastic changes of the vitreous humor
Journal Title: Офтальмологический журнал - Year 2018, Vol 0, Issue 4
Abstract
Background. Patients with profilerative vitreoretinopathy are performed vitrectomy which, however, is challenging in the presence of high visual function, transparent lenses, and single vitreoretinal adhesion bands as well as at risk of hemorrhages. Purpose. To determine the efficacy of a two-stage laser treatment, including laser photocoagulation (LP) and laser vitreolysis (LV), for vitreoretinal adhesion bands. Material and Methods. A total of forty-two patients (42 eyes) with fibroplastic changes were treated. Laser interventions were performed in two stages: 1) laser photocoagulation of the retina, in sites where the bands attached the retina, followed by 2) neodymium-doped yttrium aluminum garnet (Nd:YAG) laser vitreolysis. Accurate focusing and adjusting the optimal laser energy contribute to increased treatment efficacy. Results. At the first stage, 36 patients (86%) were performed preventive LP of newly-formed vessels of the bands and limiting LP in the sites of attachment of the bands and membranes. LP was made in the basement of the vitreoretinal bands in the sites where tractional retinal detachment could occur. At 2-3 weeks, after chorioretinal comissura had been formed, Nd:YAG LV was performed. On treatment completion, visual acuity increased by 27% in 28 patients (67%). In addition, the level of intraocular pressure almost did not change (20.0 mm Hg). The present treatment managed to dissect the vitreoretinal adhesion bands and to decrease a degree of traction in 38 patients (67%). Conclusion. The studies showed a high efficacy of a two-stage laser treatment for vitreoretinal adhesion bands which, in certain cases, can be alternative to surgical treatment, vitrectomy and endolaser photocoagulation.
Authors and Affiliations
P. Chechin, K. Drachenko, O. Guzun, S. Drachenko
Influence of local and systemic factors of type 2 diabetes mellitus on the functional status of platelets in patients with diabetic retinopathy and maculopathy
Background: To date, there is no information on relationships of systemic (activation of the sympathoadrenal and renin- angiotensin systems, SAS and RAS, respectively) and local (inflammation and remodeling of the retina...
Serum VEGF levels in infants at risk for developing retinopathy of prematurity
Background: Because excessive growth of abnormal retinal vessels in the developing eye of the premature infant underlies retinopathy of prematurity (ROP), it may be hypothesized that a change in vascular endothelial grow...
Antioxidative status as assessed by enzymatic activity in the tear fluid and by the levels of sulfur-containing protein groups in the blood and tear fluid of myopes before and after treatment with a thiol agent
Background: Myopia remains a leading cause of vision loss and visual disability in Ukraine (75%) and one of the most common ocular disorders worldwide. Most of available biological materials like blood and tear fluid can...
Efficacy of neuroprotective treatment including pyrimidine nucleotides in secondary uveitic glaucoma
Background: Secondary glaucoma is found in 18% to 38% of patients with uveitis, and is one of the most severe uveitic complications. The glaucomatous process is characterized by the progressive optic nerve neuropathy. Th...
Predicting the risk of diabetic retinopathy-associated macular edema in patients with type 2 diabetes mellitus
Background: Previously, we have reported on the value of prothrombotic platelet phenotype as a factor for the development of diabetic maculopathy (DMP) and diabetic macular edema (DME) in patients with diabetic retinopat...